Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | AR | P10275 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | PGR | P06401 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 8/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL960384 | 0.94 | LMNA (0.61) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL6498189 | 0.81 | LMNA (0.62) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL22288743 | 0.81 | AR (0.65) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL3188776 | 0.80 | ALDH1A1 (0.57) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL961124 | 0.78 | SIRT6 (0.77) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL11623150 | 0.78 | LMNA (0.58) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL28137192 | 0.77 | SIRT6 (0.75) | KMT2ALMNAMEN1SMN1; SMN2CYP1A2 | |
| SCHEMBL12478451 | 0.77 | SIRT6 (0.75) | KMT2ALMNAMEN1SMN1; SMN2CYP1A2 | |
| SCHEMBL629458 | 0.77 | AR (0.74) | KMT2ALMNAMEN1SMN1; SMN2AR | |
| SCHEMBL6140635 | 0.77 | AR (0.48) | KMT2ALMNAMEN1ARMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050182260-A1 | Process for the preparation of cyclic imides in the presence of polyphosphoric acid | MERCK PATENT GMBH (DE) | 2005-08-18 | — | — | US | disclosed |
| EP-1506173-A1 | METHOD FOR PRODUCING CYCLIC IMIDES IN THE PRESENCE OF POLYPHOSPHORIC ACID | MERCK PATENT GmbH (DE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097600-A1 | METHOD FOR PRODUCING CYCLIC IMIDES IN THE PRESENCE OF POLYPHOSPHORIC ACID | MERCK PATENT GMBH (DE) | 2003-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182260-A1 | Process for the preparation of cyclic imides in the presence of polyphosphoric acid | PPIP5K2, ITPA, IPMK | KMT2A 4192/4885LMNA 2900/4885MEN1 936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.